D. Husereau

发表

Identifying strategies to improve diabetes care in Alberta, Canada, using the knowledge-to-action cycle.

Catherine H. Yu, A. Tricco, S. Straus, 2013, CMAJ open.

Policy Options for Infliximab Biosimilars in Inflammatory Bowel Disease Given Emerging Evidence for Switching

B. Feagan, D. Husereau, C. Selya-Hammer, 2018, Applied Health Economics and Health Policy.

HEALTH TECHNOLOGY ASSESSMENT AND PERSONALIZED MEDICINE: ARE ECONOMIC EVALUATION GUIDELINES SUFFICIENT TO SUPPORT DECISION MAKING?

A. Levy, S. Peacock, D. Marshall, 2014, International Journal of Technology Assessment in Health Care.

THE EFFECT OF ENGLISH-LANGUAGE RESTRICTION ON SYSTEMATIC REVIEW-BASED META-ANALYSES: A SYSTEMATIC REVIEW OF EMPIRICAL STUDIES

Michelle Fiander, T. Clifford, J. Polisena, 2012, International Journal of Technology Assessment in Health Care.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

M. Drummond, D. Moher, E. Loder, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

David Moher, Dan Greenberg, Michael Drummond, 2013, International Journal of Technology Assessment in Health Care.

Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT)

M. Levine, L. Thabane, M. Krahn, 2021, PharmacoEconomics.

Personalized Medicine Beyond Genomics: New Technologies, Global Health Diplomacy and Anticipatory Governance.

D. Husereau, V. Ozdemir, S. Samper, 2009, Current pharmacogenomics and personalized medicine.

Supporting Informed Decisions Pegylated Interferon Combined with Ribavirin for Chronic Hepatitis C Virus Infection: An Economic Evaluation

U. Siebert, D. Husereau, Bruce Brady, 2007 .

Using Phase-Based Costing of Real-World Data to Inform Decision–Analytic Models for Atrial Fibrillation

W. Wodchis, M. Krahn, D. Husereau, 2016, Applied Health Economics and Health Policy.

Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA.

Maarten J. IJzerman, M. Drummond, A. Booth, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Evolution of drug reimbursement in Canada: the Pan-Canadian Pharmaceutical Alliance for new drugs.

Adrienne M. Blanchard, D. Husereau, W. Dempster, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB)

Kelvin K. W. Chan, G. Guyatt, T. Clifford, 2019, Medical decision making : an international journal of the Society for Medical Decision Making.

Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk

M. Tonelli, F. McAlister, B. Hemmelgarn, 2011, Canadian Medical Association Journal.

A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development

B. Manns, S. Klarenbach, C. Donaldson, 2014, PloS one.

Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement

M. Hiligsmann, D. Husereau, J. Reginster, 2022, Osteoporosis International.

Omapatrilat for the management of heart failure and hypertension.

D. Husereau, 2001, Issues in emerging health technologies.

Citation Impact was Highly Variable For Reporting Guidelines of Health Research: A Citation Analysis.

D. Moher, D. Altman, F. Catalá-López, 2020, Journal of clinical epidemiology.

Economic evaluations of eHealth technologies: A systematic review

P. Stolee, D. Husereau, D. Juzwishin, 2018, PloS one.

Health Utility Book (HUB)–Cancer: Protocol for a Systematic Literature Review of Health State Utility Values in Cancer

Kelvin K. W. Chan, G. Guyatt, T. Clifford, 2019, MDM policy & practice.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

M. Drummond, D. Moher, E. Loder, 2013, BJOG : an international journal of obstetrics and gynaecology.

How do Economic Evaluations Inform Health Policy Decisions for Treatment and Prevention in Canada and the United States?

A. Culyer, P. Neumann, D. Husereau, 2015, Applied Health Economics and Health Policy.

A synthesis of drug reimbursement decision-making processes in organisation for economic co-operation and development countries.

B. Manns, S. Klarenbach, C. Donaldson, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.

M. Drummond, S. Staniszewska, D. Husereau, 2022, Clinical therapeutics.

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations.

M. Drummond, S. Staniszewska, D. Husereau, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

S. Staniszewska, D. Husereau, L. Caulley, 2022, PharmacoEconomics.

Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis.

D. Coyle, K. Cimon, D. Husereau, 2011, CADTH technology overviews.

Imatinib mesylate for chronic myeloid leukemia: what do we really know?

D. Husereau, 2002, Issues in emerging health technologies.

Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force

A. Culyer, K. Facey, D. Husereau, 2022, International Journal of Technology Assessment in Health Care.

Teriparatide and Bisphosphonates for Treatment of Osteoporosis in Women : A Clinical and Economic Analysis Technology Report

D. Coyle, D. Husereau, B. Skidmore, 2006 .

Guidelines for health technologies: specific guidance for oncology products in Canada.

D. Coyle, S. Peacock, H. Au, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

THC volume 31 issue 6 Cover and Back matter

M. Hallett, D. Avard, D. Husereau, 2015, International Journal of Technology Assessment in Health Care.

Health technology assessment in Canada

R. Battista, M. Hodge, D. Husereau, 2009, International Journal of Technology Assessment in Health Care.

Use of Real-World Data Sources for Canadian Drug Pricing and Reimbursement Decisions: Stakeholder Views and Lessons for Other Countries

D. Husereau, Edward Nason, P. Jacobs, 2019, International Journal of Technology Assessment in Health Care.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement

M. Drummond, D. Moher, E. Loder, 2013, PharmacoEconomics.

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

M. Drummond, E. Loder, S. Staniszewska, 2022, Applied Health Economics and Health Policy.

Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force

A. Culyer, K. Facey, D. Husereau, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Matching‐adjusted comparison of oral corticosteroid reduction in asthma: Systematic review of biologics

D. Husereau, N. Molinari, A. Bourdin, 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review

D. Husereau, N. Molinari, A. Bourdin, 2018, European Respiratory Journal.

How do we value a cure?

D. Husereau, 2015, Expert review of pharmacoeconomics & outcomes research.

Incorporating economic evaluation into immunization decision making in Canada: a workshop

D. Fisman, A. Chit, J. Langley, 2014, Expert review of vaccines.

A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies.

T. Friede, J. Karnon, Stephen Palmer, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis

M. Mamdani, G. Wells, A. Hossain, 2020, PloS one.

PNS18 IMPROVING THE APPLICATION OF PUBLISHED HEALTH UTILITIES IN COST-UTILITY ANALYSES: DEVELOPMENT OF THE HEALTH UTILITY APPLICATION TOOL (HAT)

Gordon H. Guyatt, Murray Krahn, Don Husereau, 2020 .

Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients

D. Husereau, N. Leighl, B. Melosky, 2021, Current oncology.

Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement

M. Hiligsmann, D. Husereau, J. Reginster, 2022, Osteoporosis International.

Effective and Efficient Delivery of Genome-Based Testing-What Conditions Are Necessary for Health System Readiness?

S. Yip, D. Husereau, L. Steuten, 2022, Healthcare.

Ezetimibe for lowering blood cholesterol.

D. Husereau, 2003, Issues in emerging health technologies.

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

M. Drummond, P. Scuffham, D. Moher, 2022, The European Journal of Health Economics.

Cost-effectiveness and budget impact of the management of uncomplicated urinary tract infection by community pharmacists

R. Tsuyuki, D. Husereau, Nathan P. Beahm, 2019, BMC Health Services Research.

Optimizing the delivery of genetic and advanced diagnostic testing in the province of Ontario: challenges and implications for laboratory technology assessment and management in decentralized healthcare systems

H. Feilotter, T. Stockley, D. Husereau, 2022, Journal of medical economics.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

M. Drummond, D. Moher, E. Loder, 2013, International Journal of Technology Assessment in Health Care.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

David Moher, Dan Greenberg, Michael Drummond, 2013, Cost Effectiveness and Resource Allocation.

Personalized Medicine and Health Care Policy: From Science to Value

C. McCabe, D. Husereau, Karine Morin Director, 2014 .

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.

David Moher, Dan Greenberg, Michael Drummond, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

M. Drummond, D. Moher, E. Loder, 2013, The European Journal of Health Economics.

Community-Based Services by Pharmacists: A Systematic Review of Cost-Utility Analyses.

D. Husereau, C. Sanyal, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

M. Drummond, D. Moher, E. Loder, 2013, BMJ.

Delivering precision oncology to patients with cancer

J. Reis-Filho, N. Normanno, E. Voest, 2022, Nature Medicine.

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations

M. Drummond, E. Loder, S. Staniszewska, 2022, BMJ.

Reproducible research practices, openness and transparency in health economic evaluations: study protocol for a cross-sectional comparative analysis

M. Drummond, D. Moher, F. Catalá-López, 2020, BMJ Open.

Clinical Pharmacology: Advances and Applications Dovepress Systematic Review and Network Meta-analysis of Stroke Prevention Treatments in Patients with Atrial Fibrillation

H. Boon, M. Krahn, D. Husereau, 2022 .

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

M. Drummond, D. Moher, E. Loder, 2013, Clinical therapeutics.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force.

M. Drummond, S. Staniszewska, D. Husereau, 2022, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A general affinity method to purify peroxidase-tagged antibodies.

D. Husereau, M. Suresh, 2001, Journal of immunological methods.

Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

M. Drummond, C. Mullins, S. Staniszewska, 2022, International Journal of Technology Assessment in Health Care.

Severe, eosinophilic asthma in primary care in Canada: a longitudinal study of the clinical burden and economic impact based on linked electronic medical record data

D. Husereau, R. Leigh, A. Gendron, 2018, Allergy, Asthma & Clinical Immunology.

Collaborative authoring: a case study of the use of a wiki as a tool to keep systematic reviews up to date

Amol Deshpande, Alejandro R Jadad, Jacqueline L Bender, 2011, Open medicine : a peer-reviewed, independent, open-access journal.

Long acting β2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trials

R. Dales, D. Husereau, M. Boucher, 2004, BMC pulmonary medicine.

Long acting 2 agonists for stable chronic obstructive pulmonary disease: a systematic review of randomised controlled trials.

R. Dales, D. Husereau, M. Boucher, 2002 .

Priority setting for health technology assessments: A systematic review of current practical approaches

Becky Skidmore, Don Husereau, H. Noorani, 2007, International Journal of Technology Assessment in Health Care.

Priority setting for health technology assessments: A systematic review of current practical approaches

Becky Skidmore, Hussein Z Noorani, H. Noorani, 2007, International Journal of Technology Assessment in Health Care.

Economic guidelines for oncology products: Adaptation of the Canadian Agency for Drugs and Technologies in Health (CADTH) technology assessment guidance document.

N Mittmann, D. Coyle, H. Au, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Wait times among patients with symptomatic carotid artery stenosis requiring carotid endarterectomy for stroke prevention.

D. Husereau, T. Brandys, P. Jetty, 2012, Journal of vascular surgery.

A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report.

C Daniel Mullins, Bradley C Martin, Marc L Berger, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Trends in the utilization of endovascular therapy for elective and ruptured abdominal aortic aneurysm procedures in Canada.

D. Husereau, P. Jetty, 2012, Journal of vascular surgery.

MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONS

D. Husereau, P. Jacobs, Ilke Akpinar, 2015, International Journal of Technology Assessment in Health Care.

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

M. Drummond, E. Loder, S. Staniszewska, 2022, BMC Medicine.

CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?

Laura Sampietro-Colom, Chris Henshall, Don Husereau, 2016, International Journal of Technology Assessment in Health Care.

Reporting guidelines of health research studies are frequently used inappropriately.

D. Moher, D. Altman, F. Catalá-López, 2020, Journal of clinical epidemiology.

Variability in aneurysm sac regression after endovascular aneurysm repair based on a comprehensive registry of patients in Eastern Ontario.

D. Husereau, P. Jetty, V. Kansal, 2019, Journal of vascular surgery.

Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists

D. Husereau, C. Sanyal, 2019, Applied Health Economics and Health Policy.

Statins for primary prevention

M. Tonelli, B. Manns, D. Husereau, 2012, Canadian Medical Association Journal.

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis

M. Tonelli, F. McAlister, B. Hemmelgarn, 2011, Canadian Medical Association Journal.

Priority setting for health technology assessment at CADTH

Michel Boucher, Don Husereau, H. Noorani, 2010, International Journal of Technology Assessment in Health Care.

Asynchronous telehealth: a scoping review of analytic studies

Alejandro R Jadad, Shariq Khoja, Ann McKibbon, 2009, Open medicine : a peer-reviewed, independent, open-access journal.

Evidence and its impact on pharmacy practice: Don’t be “evidence-illiterate”

R. Tsuyuki, D. Husereau, C. Sanyal, 2018, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

Health technology assessment: a review of international activity and examples of approaches with computed tomographic colonography.

R. Goeree, R. Battista, D. Husereau, 2009, Journal of the American College of Radiology : JACR.

A Beginner's Guide to Understanding Curative Therapies.

D. Husereau, S. Reed, 2019, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

M. Drummond, S. Staniszewska, D. Husereau, 2022, BMC Health Services Research.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

M. Drummond, D. Moher, E. Loder, 2013, The European Journal of Health Economics.

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration

F. Dionne, A. Denburg, Marianne Taylor, 2023, Current Oncology.

Economic Evaluation of Complex Health System Interventions: a Discussion Paper

B. Manns, R. Tamblyn, D. Marshall, 2014 .

ADAPTIVE APPROACHES TO LICENSING, HEALTH TECHNOLOGY ASSESSMENT, AND INTRODUCTION OF DRUGS AND DEVICES

Chris Henshall, Don Husereau, Jamil Jivraj, 2014, International Journal of Technology Assessment in Health Care.

Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists

Kelvin K. W. Chan, M. Levine, J. Brazier, 2021, The European Journal of Health Economics.

Progress toward Health System Readiness for Genome-Based Testing in Canada

S. Yip, D. Husereau, L. Steuten, 2023, Current oncology.

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations

M. Drummond, E. Loder, S. Staniszewska, 2022, BMJ.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement.

M. Drummond, D. Moher, E. Loder, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Capturing Value from Health Technologies in Lean Times

D. Husereau, Å. Blomqvist, C. Busby, 2013 .

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

David Moher, Dan Greenberg, Michael Drummond, 2013, Journal of medical economics.

Oncology Modeling for Fun and Profit! Key Steps for Busy Analysts in Health Technology Assessment

Neil Hawkins, Don Husereau, Kelvin K. W. Chan, 2017, PharmacoEconomics.

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

M. Drummond, D. Moher, E. Loder, 2013, BMJ.

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

M. Drummond, S. Staniszewska, D. Husereau, 2022, BMC Public Health.

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

A. Briggs, S. Staniszewska, C. Mullins, 2022, BJOG : an international journal of obstetrics and gynaecology.

Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis

M. Tonelli, F. McAlister, B. Hemmelgarn, 2011, Canadian Medical Association Journal.

M. Drummond, D. Moher, E. Loder, 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Editorial [Sentence First, Verdict Afterwards: Using Value of Information Analysis to Inform Decisions about Pharmacogenomic Test Adoption and Research]

D. Husereau, 2010 .

Octaplas Compared with Fresh Frozen Plasma to Reduce the Risk of Transmitting Lipid-Enveloped Viruses: An Economic Analysis and Budget Impact Analysis

K. Cimon, D. Husereau, A. Tinmouth, 2011 .

Redefining Health Technology Assessment: A Comment on “The New Definition of Health Technology Assessment: A Milestone in International Collaboration”

A. Culyer, D. Husereau, 2022, International Journal of Technology Assessment in Health Care.